Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Baylor/Richardson Cancer Center
mi
from
Richardson, TX
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Baylor/Richardson Cancer Center
mi
from
Richardson, TX
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Scott and White Hospital
mi
from
Temple, TX
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Scott and White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
The University of Texas Health Center at Tyler
mi
from
Tyler, TX
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
The University of Texas Health Center at Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Green Mountain Oncology Group
mi
from
Bennington, VT
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Green Mountain Oncology Group
mi
from
Bennington, VT
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Southwestern Vermont Regional Cancer Center
mi
from
Bennington, VT
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Southwestern Vermont Regional Cancer Center
mi
from
Bennington, VT
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Mountainview Medical
mi
from
Berlin, VT
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Mountainview Medical
mi
from
Berlin, VT
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Vermont Cancer Center at University of Vermont
mi
from
Burlington, VT
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Vermont Cancer Center at University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Community Cancer Center at Rutland Regional Medical Center
mi
from
Rutland, VT
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Community Cancer Center at Rutland Regional Medical Center
mi
from
Rutland, VT
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Martha Jefferson Hospital
mi
from
Charlottesville, VA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Martha Jefferson Hospital
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Cancer Center of the Piedmont, Inc.
mi
from
Danville, VA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Cancer Center of the Piedmont, Inc.
mi
from
Danville, VA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Danville Hematology and Oncology, Incorporated
mi
from
Danville, VA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Danville Hematology and Oncology, Incorporated
mi
from
Danville, VA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Virginia Oncology Associates - Newport News
mi
from
Newport News, VA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Virginia Oncology Associates - Newport News
mi
from
Newport News, VA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Henrico Doctors' Hospital - Parham Campus
mi
from
Richmond, VA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Henrico Doctors' Hospital - Parham Campus
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Oncology and Hematology Associates of Southwest Virginia
mi
from
Roanoke, VA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Oncology and Hematology Associates of Southwest Virginia
mi
from
Roanoke, VA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
St. Joseph Hospital Community Cancer Center
mi
from
Bellingham, WA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
St. Joseph Hospital Community Cancer Center
mi
from
Bellingham, WA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Olympic Hematology and Oncology
mi
from
Bremerton, WA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Olympic Hematology and Oncology
mi
from
Bremerton, WA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Flynn Cancer Center at Providence Everett Medical Center - Pacific Campus
mi
from
Everett, WA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Flynn Cancer Center at Providence Everett Medical Center - Pacific Campus
mi
from
Everett, WA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
mi
from
Seattle, WA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Cancer Care Northwest - Spokane North
mi
from
Spokane, WA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Cancer Care Northwest - Spokane North
mi
from
Spokane, WA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Rockwood Clinic, PS
mi
from
Spokane, WA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Rockwood Clinic, PS
mi
from
Spokane, WA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Northwest
mi
from
Tacoma, WA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Yakima Regional Cancer Care Center
mi
from
Yakima, WA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Yakima Regional Cancer Care Center
mi
from
Yakima, WA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
David Lee Cancer Center at Charleston Area Medical Center
mi
from
Charleston, WV
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
David Lee Cancer Center at Charleston Area Medical Center
mi
from
Charleston, WV
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Camden-Clark Memorial Hospital
mi
from
Parkersburg, WV
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Camden-Clark Memorial Hospital
mi
from
Parkersburg, WV
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Aurora Sinai Medical Center
mi
from
Milwaukee, WI
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Aurora Sinai Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Oncology Alliance, S.C.
mi
from
Milwaukee, WI
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Oncology Alliance, S.C.
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Waukesha Memorial Hospital Regional Cancer Center
mi
from
Waukesha, WI
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Waukesha Memorial Hospital Regional Cancer Center
mi
from
Waukesha, WI
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
UW Cancer Center Wausau Hospital
mi
from
Wausau, WI
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
UW Cancer Center Wausau Hospital
mi
from
Wausau, WI
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Tom Baker Cancer Center - Calgary
mi
from
Calgary,
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Tom Baker Cancer Center - Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Clearview Cancer Institute
mi
from
Huntsville, AL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Clearview Cancer Institute
mi
from
Huntsville, AL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Providence Cancer Center
mi
from
Anchorage, AK
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Providence Cancer Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Banner Thunderbird Medical Center
mi
from
Glendale, AZ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Banner Thunderbird Medical Center
mi
from
Glendale, AZ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Banner Good Samaritan Medical Center
mi
from
Phoenix, AZ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Banner Good Samaritan Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Western Regional, Arizona
mi
from
Phoenix, AZ
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Western Regional, Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Alta Bates Summit Comprehensive Cancer Center
mi
from
Berkeley, CA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Alta Bates Summit Comprehensive Cancer Center
mi
from
Berkeley, CA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Peninsula Medical Center
mi
from
Burlingame, CA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Peninsula Medical Center
mi
from
Burlingame, CA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
East Bay Radiation Oncology Center
mi
from
Castro Valley, CA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
East Bay Radiation Oncology Center
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Valley Medical Oncology Consultants - Castro Valley
mi
from
Castro Valley, CA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Valley Medical Oncology Consultants - Castro Valley
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
North Bay Cancer Center
mi
from
Fairfield, CA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
North Bay Cancer Center
mi
from
Fairfield, CA
Click here to add this to my saved trials